Adial Pharmaceuticals Inc (ADIL) — Strategic Asset Allocation Index
Adial Pharmaceuticals Inc (ADIL) has a Strategic Asset Allocation Index of 11.3% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $421.73K) total $421.73K, measured against net assets of $3.72 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ADIL equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Adial Pharmaceuticals Inc Strategic Asset Allocation Index (2021–2025)
This chart shows how Adial Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 11.3%, representing strategic assets of $421.73K against net assets of $3.72 Million USD. For live market cap and overall valuation, see how much is Adial Pharmaceuticals Inc worth.
Annual Strategic Asset Allocation Index for Adial Pharmaceuticals Inc (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Adial Pharmaceuticals Inc from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Adial Pharmaceuticals Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 9.3% | $489.70K | $- | $489.70K | $5.28 Million | ▼ -14.9 pp |
| 2024 | 24.1% | $981.83K | $- | $981.83K | $4.07 Million | ▼ -13.4 pp |
| 2023 | 37.6% | $1.53 Million | $- | $1.53 Million | $4.08 Million | ▲ +37.6 pp |
| 2022 | 0.0% | $0.00 | $- | $0.00 | $3.28 Million | ▼ -8.7 pp |
| 2021 | 8.7% | $304.36K | $304.36K | $- | $3.51 Million | — |